Polyglycan##R## (Rx)

Winning in their blood, Polyglycan in their joints

Category: Joint & Cartilage Support

Active Ingredient(s): hyaluronic acid + chondroitin sulfates C4 & C6 + N-acetyl-D-glucosamine sterile solution

Download(s)

What is Polyglycan^®?

Polyglycan^® is a patented formulation of hyaluronic acid, sodium chondroitin sulfate, and N-acetyl-D-glucosamine in a highly viscous aqueous solution for use in horses and dogs. Glucosaminoglycans are important components of extracellular tissue structures, including cartilage and synovial fluid.

Indications

Polyglycan^® is indicated for the replacement of lost or damaged synovial fluid. Polyglycan^® contains naturally occurring components of the synovia that play a central part in maintaining the homeostatic environment of the joint.

Polyglycan Formats

POLYGLYCAN

Supplied in cartons (6 x 10mL vials)
Refrigerated product

Each 10mL vial contains:

Hyaluronic acid sodium salt50 mg
Sodium chondroitin sulfate1000 mg
N-acetyl-D-glucosamine1000 mg

Download Data Sheet Safety Sheet

POLYGLYCAN-HV

HV = High Viscosity
Supplied in individual carton, single syringe label-sealed in a blister tray
2.5 mL prefilled syringes
Refrigerated product

Each 2.5mL prefilled syringe contains:

Hyaluronic acid sodium salt20 mg
Sodium chondroitin sulfate250 mg
N-acetyl-D-glucosamine125 mg

Download Data Sheet Safety Sheet

POLYGLYCAN-SA

SA = Single Administration or Small Animal
Supplied in cartons (6 x 2.5mL vials)
Refrigerated product

Each 2.5mL vial contains:

Hyaluronic acid sodium salt12.5 mg
Sodium chondroitin sulfate250 mg
N-acetyl-D-glucosamine250 mg

Download Data Sheet Safety Sheet

Properties

Glucosaminoglycans are important components of all extracellular tissue structures including cartilage and synovial fluid.
The active components in Polyglycan show viscoelastic and polyionic properties similar in nature to synovial fluid.
Patented 3-component formula has demonstrated characteristics beyond any of these components used individually.

Benefits

Help replenish lost synovial fluid with naturally occurring elements
Assists in normalization of synovial fluid viscosity
Post-surgical lavage of the joint cavity and surfaces
Patented formulation
Convenient pre-filled syringe (Polyglycan^®-HV)

Consult with your veterinarian if you suspect your horse may have Osteoarthritis or other disease as the clinical signs can vary.

Polyglycan - Robert Hunt

I have continued to use Polyglycan^® as a standard postoperative parenteral treatment as well for essentially all of my orthopedics.
I have encountered no adverse effects either locally within the joint or any systemic reactions from either route of administration of Polyglycan^®.

Robert J. Hunt, DVM, MS, Diplomate
ACVS Hagyard Equine Medical Institute, Lexington, KY

Veterinarian response to a recently published study & article that raised concerns of Polyglycan^® safety if adminstered intravenously.

Polyglycan - Chris Morrow

We’ve used over 50,000 mL of Polyglycan^® in our practice giving us a high level of comfort and confidence in its applications.
To date there have been no adverse events to be reported by our clients or our practice.
Through my peer group I have not had conversations to suggest that their experience has been different. In my opinion, application of Polyglycan^® has benefitted the joint health and the overall well-being of horses that I have had the privilege to be the caregiver.

Chris Morrow, DVM
Mobile Veterinary Practice, Amarillo, TX

Veterinarian response to a recently published study & article that raised concerns of Polyglycan^® safety if adminstered intravenously.

Polyglycan - C.R. Johnson

the findings of this study do not correlate with what I have seen in 9 years of using this product in a clinical setting, and I disagree with the conclusion that Polyglycan^® may be harmful to the joint when administered IV.
Although the experimental model used in this study is the best model available for measuring changes in the joint environment using different medications, in my opinion, the model, as an acute chip fracture, does not replicate the disease process that I see in practice. Hopefully, the findings of this article will lead to new experiments & new discoveries about the processes involved with osteoarthritis.

C.R. Johnson, DVM, MS, DACVS
Equine Surgical Services, Versailles, KY

Veterinarian response to a recently published study & article that raised concerns of Polyglycan^® safety if adminstered intravenously.

Pack Sizes


List No.	Pack Size	Case Size
Polyglycan (1POL007)	6x10mL vials	40
Polyglycan-HV (1POL008)	2.5 mL prefilled / 5mL syringe	40
Polyglycan-SA (1POL009)	6 x 2.5 mL vials	60